NCT00331201View on ClinicalTrials.gov

SAFEstart Feeding Intolerance Study Phase II

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

April 30, 2006

Conditions
Feeding IntoleranceAbdominal DistentionGastric ResidualEmesis and DiarrheaBlood in Stool
Interventions
DRUG

SAFEstart

Trial Locations (1)

84403

McKay-Dee Hospital Center, Ogden

All Listed Sponsors
lead

Intermountain Health Care, Inc.

OTHER

NCT00331201 - SAFEstart Feeding Intolerance Study Phase II | Biotech Hunter | Biotech Hunter